2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Cifra de Afaceri - Ron | - | 33.765 | 254.133 | 407.090 | 555.262 | 634.584 | 855.704 | 984.791 | 1.294.659 | 1.273.298 |
Venituri Totale - Ron | - | 33.765 | 254.133 | 407.109 | 555.268 | 634.889 | 855.797 | 984.871 | 1.294.675 | 1.273.305 |
Cheltuieli Totale - Ron | - | 53.535 | 235.021 | 386.199 | 493.650 | 539.524 | 713.185 | 813.802 | 1.089.662 | 1.103.031 |
Profit/Pierdere Brut - Ron | - | -19.770 | 19.112 | 20.910 | 61.618 | 95.365 | 142.612 | 171.069 | 205.013 | 170.274 |
Profit/Pierdere Net - Ron | - | -20.783 | 16.571 | 16.840 | 56.064 | 89.015 | 134.683 | 161.417 | 192.599 | 159.443 |
Salariati | - | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 |
Verifica rapoartele financiare pentru firma - Oituz Pharma Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Active Imobilizate | - | 9.088 | 6.510 | 4.943 | 3.825 | 4.451 | 9.402 | 8.313 | 9.348 | 6.913 |
Active Circulante | - | 30.319 | 64.435 | 72.035 | 139.871 | 202.889 | 350.314 | 531.648 | 588.620 | 763.742 |
Stocuri | - | 29.052 | 56.117 | 40.214 | 57.222 | 57.573 | 97.125 | 116.300 | 110.705 | 175.563 |
Creante | - | 0 | 0 | 21.887 | 23.380 | 20.078 | 38.262 | 56.229 | 110.724 | 66.010 |
Casa si conturi | - | 1.267 | 8.318 | 9.934 | 59.269 | 125.238 | 214.927 | 359.119 | 367.191 | 522.169 |
Capitaluri Proprii | - | -20.583 | -4.012 | 12.827 | 68.891 | 157.906 | 292.589 | 454.006 | 485.605 | 645.048 |
Capital Social | - | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 |
Datorii | - | 59.990 | 74.957 | 64.151 | 74.805 | 49.434 | 67.127 | 85.955 | 112.363 | 125.607 |
Venituri in Avans | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Curs valutar - RON | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
CAEN Principal | "4773 - 4773" | |||||||||
CAEN An Financiar |
4773
|
Abonamente Rapoarte Financiare
Poti verifica nelimitat situatia financiara a firmelor raportata la industria din care face parte, limitele de creditare si riscul de insolventa si de oprire al conturilor.
Comentarii - Oituz Pharma Srl